Skip to main
SEPN

Septerna Inc (SEPN) Stock Forecast & Price Target

Septerna Inc (SEPN) Analyst Ratings

Based on 7 analyst ratings
Strong Buy
Strong Buy 71%
Buy 29%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Septerna is a promising clinical-stage biotechnology company with a strong proprietary Native Complex Platform that has the potential to unlock the full potential of GPCR therapies. The company has a diversified pipeline of product candidates targeting various therapeutic areas, which could lead to significant revenue potential in the future. With positive data from the Phase 1 clinical trial of its lead candidate SEP-479 and potential lead candidate selection from its TSHR NAM program by the end of this year, Septerna is poised for growth and success in the coming years.

Bears say

Septerna is currently facing significant valuation and risk concerns as evidenced by an 11% discount rate, conservative market assumptions, and a 30% probability of approval for their lead candidate, SEP-479. Additionally, risks to price target achievement include delays in advancing other candidates, setbacks in clinical trials, and possible partnership risks. Though the company has a strong cash position, with enough funds to last until 2029, it remains to be seen if their lead candidate, SEP-631, will meet expectations in mast cell-driven diseases such as chronic inducible urticaria and other inflammatory indications. Overall, given recent competitor data and a reduced 25% probability of success for SEP-631 in CSU, the company's valuation and market share estimates have been adjusted accordingly.

Septerna Inc (SEPN) has been analyzed by 7 analysts, with a consensus rating of Strong Buy. 71% of analysts recommend a Strong Buy, 29% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Septerna Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Septerna Inc (SEPN) Forecast

Analysts have given Septerna Inc (SEPN) a Strong Buy based on their latest research and market trends.

According to 7 analysts, Septerna Inc (SEPN) has a Strong Buy consensus rating as of Sep 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $52.43, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $52.43, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Septerna Inc (SEPN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.